Epidemiological profile of cancer for Grand Bahama residents: 1988-2002 / Perfil epidemiológico del cáncer en los residentes de gran bahama: 1988 ­ 2002

This retrospective and observational study is based on a review of data from the pathology ledgers and clinical records of the Rand Memorial Hospital, of diagnoses and deaths from cancer from 1988 to 2002 (15 years). The aim was to determine the cancer incidence, mortality, survival rates and the trends for the island of Grand Bahama, Bahamas. The records indicated at least 545 (males: 187; females: 358) new cancer diagnoses giving an approximate age-standardized annual incidence rate of 167.7 per 100,000. The most frequent cancers were, in males (except for skin keratinocytic cancers) prostate 21.9, colon/rectum 12.8and lung 6.4; and in females: breast 45.3, cervix uteri 16.8and colon/rectum 6.4. Of these cancers, 443 (81.3) were diagnosed in the pathology department of the hospital with the median age at diagnosis of all persons being 52 years. This comprised 119 males and 324 females. Whereas the majority of breast and cervical cancers were histologically diagnosed locally, those of prostate and lung were not. During the period, 359 (males: 181; females: 178) persons had died from cancer; an annual age-standardized mortality rate of 114.8 per 100,000, with breast 19.2, prostate 14.5and colon/rectum 9.5being the most frequent. The overall median period of survival was one year (range 0-14 years). The median survival for persons with cervix uteri was five years; for breast cancer, three years; colorectal cancer, 2 years; prostate, one year; and less than a year for lung cancer. The data on cancer were not easily obtained and this may be improved if a cancer registry is established on this second most populated island of The Bahamas.

Este estudio retrospectivo y de observación se basa en una revisión de datos de los libros de registros de patologías y las historias clínicas del Hospital Rand Memorial, en relación con el diagnóstico y las muertes de cáncer desde 1988 hasta el 2002 (15 años). El objetivo fue determinar la incidencia de cáncer, la mortalidad, las tasas de supervivencia y las tendencias, con respecto a la isla de Gran Bahamas, Bahamas. Los registros indicaron al menos 545 (varones: 187; hembras: 358) diagnósticos nuevos de cáncer, para una tasa de incidencia anual estandarizada por edad, de aproximadamente 1677 por 100000. Los tipos más frecuentes de cáncer fueron los siguientes. En los hombres (con excepción de los cánceres queratinocíticos de la piel): próstata, 21.9%; colon/recto 12.8%; y pulmón, 6.4%. En las mujeres: mamas, 45.3%, cervical uterino, 16.8%; y colon/recto 6.4%. De estos tipos de cáncer, el 81.3%, es decir, 443 (varones: 119; hembras: 324), fueron diagnosticados en el departamento de patología del hospital, con una edad mediana de 52 años en relación con todos los pacientes en el momento del diagnóstico. Mientras que la mayoría de los cánceres de cervical y de mamas se diagnosticaron histológicamente de forma local, los de próstata y pulmón no se diagnosticaron de ese modo. Durante ese período, un total de 359 personas (181 varones; 178 hembras) habían muerto de cáncer, para una tasa anual de mortalidad estandarizada por edad, de 114.8 por 100 000, siendo los cánceres de mama (19.2%), próstata (14.5%), y el colorrectal (9.5%) los más frecuentes. La mediana general del período de supervivencia fue de un año (rango 0 ­ 14). Después del diagnóstico, las personas continuaron viviendo con cáncer una mediana de cinco años en el caso del cáncer cervical

Genital herpes in Jamaica: a clinical and pathological study 1982-1984

Five hundred and four patients with suspected genital simplex virus (HSV) infection were investigated in Jamica between 1982 and 1984. Of these, 100 (1908%) were virologically confirmed. There were 12 patients with primary/first episode, 45 recurrente and 6 "provoked" type of genital herpes simplex virus infections. Genital herpes in women was more severe than in men. Eighty-eight per cent of genital herpes was confirmed by virus isolation. Forty HSF isolates were identified as HSV type 2. There was seroresponse in 75% primary, 18% recurrent and 17% provoked type of genital herpes. Virus isolation is the most sensitive and specific test for the diagnosis of genital herpes simplex virus infection. The measuremem of serum anti herpes simplex complement-fixing antibodies was not useful in the diagnosis of suspected patients with genital ulcers and their contacts. The infectiousness of the virus, clinical manifestations, complications such as neonatal herpes infections, psychosocial problems and methods of prevention are issues that clinicians should discuss with patients with genital herpes